Next-generation medicines unlocked from and tailored to individual humans11-50 Employees
- B2B
- Growth StageExpanding market presence
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
Verge Genomics Funding
$0
22 rounds
Y Combinator
Verge Genomics is active in the following markets / industries: biotechnology, health care, pharmaceuticals, neuroscience, genetic testing and Drug discovery. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on July 16, 2018.
Funding Rounds
S
$4000000
Investors of Verge Genomics
Dave Morin
Entrepreneur
Never climb alone
Rounds
S
Early-stage venture fund with a focus on artificial intelligence
Partner @Great Oaks Venture Capital • Marketplaces, Consumer, B2B, Health • @New York City
Backing extraordinary entrepreneurs who think big
Rounds
A
Wuxi New Venture fund
Rounds
A
OS Fund
Rounds
A
NFT Curator & Builder | Angel Investor & LP | Alum of @Y Combinator
Investor, Founder @Medina Medical (Acquired by Medtronic) , Worked @Google, Morgan Stanley, Studied at American University